Literature DB >> 6861849

Bioavailability and pharmacokinetics of theophylline following plain uncoated and sustained-release dosage forms in relation to smoking habit. II. Multiple dose study.

T Ishizaki, Y Horai, T Sasaki, K Chiba, A Ohnishi, T Suganuma, G Tsujimoto, H Echizen, T Okaniwa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6861849     DOI： 10.1007/bf00610056

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  30 in total

1.  Effect of smoking on theophylline disposition.

Authors:  S N Hunt; W J Jusko; A M Yurchak
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

2.  Relationship of theophylline clearance to oral dosage in children with chronic asthma.

Authors:  E Ginchansky; M Weinberger
Journal:  J Pediatr       Date:  1977-10       Impact factor: 4.406

3.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

4.  Diurnal rhythms of aminopyrine metabolism: failure to sleep deprivation to affect them.

Authors:  G E Poley; C A Shively; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1978-12       Impact factor: 6.875

5.  Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.

Authors:  Y Horai; T Ishizaki; T Sasaki; K Chiba; T Suganuma; H Echizen; A Ohnishi
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Clinical toxocity of theophylline in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  H J Pfeifer; D J Greenblatt
Journal:  Chest       Date:  1978-04       Impact factor: 9.410

7.  No circadian effect on nortriptyline kinetics in man.

Authors:  S Nakano; L E Hollister
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

8.  Efficacy of a 12-hour sustained-release preparation in maintaining therapeutic serum theophylline levels in asthmatic children.

Authors:  H W Kelly; S Murphy
Journal:  Pediatrics       Date:  1980-07       Impact factor: 7.124

9.  Theophylline bioavailability following chronic dosing of an elixir and two solid dosage forms.

Authors:  D D Shen; M Fixley; D L Azarnoff
Journal:  J Pharm Sci       Date:  1978-07       Impact factor: 3.534

10.  Dose-dependent elimination kinetics of theophylline.

Authors:  L J Lesko
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447
View more
  2 in total

Review 1.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 2.  Differential pharmacokinetics of theophylline in elderly patients.

Authors:  Akihiro Ohnishi; Motokazu Kato; Jun Kojima; Hideki Ushiama; Maki Yoneko; Hiroyuki Kawai
Journal:  Drugs Aging       Date:  2003       Impact factor: 4.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.